Niosomes - A PromisingCarrier for Drug Delivery


  • Sultan Ahmad Global Institute of Pharmaceutical Education and Research, Kashipur, India
  • Deepak Teotia Global Institute of Pharmaceutical Education and Research, Kashipur, India
  • Kapil Kumar Global Institute of Pharmaceutical Education and Research, Kashipur, India



Niosomes, non-ionic surfactants, ionic drug carriers, bioavailability


Niosomes are non-ionic surfactant based multilamellar or unilamellar vesicles in which an aqueous solution of solute is entirely enclosed by a membrane resulting from the organization of surfactant macromolecules as bilayer. The term "Niosomes" is named as because vesicle is composed of a bilayer of non-ionic surface-active agents (non-ionic surfactants). Niosomes are a novel drug delivery system, in which the medication is encapsulated in a vesicle. The ionic drug carriers are relatively toxic and unsuitable whereas niosomal carriers are safer. Also handling and storage of niosomes require no special conditions. Niosomes proved to be a promising drug carrier and has potential to reduce the side effects of drugs and increased therapeutic effectiveness in various diseases. Niosomes tackle the problem of insolubility, instability, low bioavailability and rapid degradation of drugs.Present review article deals with advantages, preparations, evaluation and pharmaceutical applications of niosomes.


Download data is not yet available.


Tavano L, Muzzalupo R, Picci N, De Cindio N. Co-encapsulation of antioxidants into niosomal carriers: gastrointestinal release studies for nutraceutical applications, Colloids and Surfaces B: Biointerfaces. 2014,114, 82-88.

Shah N, Characterization, optimization and formulation of niosome containing naproxen, J. Biomed. Pharm. Res. 2016, 5 (1), 1-6.

Han W, Wang S, Liang R. Non-ionic surfactant vesicles simultaneously enhance antitumor activity and reduce the toxicity of cantharidin," Int. J. Nanomed. 2013, 8, 2187-2196.

Shaker DS, Shaker MA, Hanafy MS, Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes, Int. J. of Pharm. 2015, 493(1-2), 285-294.

Mavaddati MA, Moztarzadeh F, Baghbani F, Effect of formulation and processing variables on dexamethasone entrapment and release of niosomes. J. Clust. Sci. 2015, 26(6), 2065-2078.

Sohrabi S, Haeri A, Mahboubi A, Mortazavi A, Dadashzadeh S. Chitosan gel-embedded moxifloxacin niosomes: an efficient antimicrobial hybrid system for burn infection, Int. J. Biol. Macro., 85, 625-633, 2016.

Khalil RA, Zarari AHA. Theoretical estimation of the critical packing parameter of amphiphilic self-assembled aggregates. App. Surf. Sci. 2014, 318, 85-89.

WadekarPradnya Pradeep, Patil Jyoti Ashok. A review on gold nanoparticles synthesis and characterization. Universal Journal of Pharmaceutical Research. 2017; 2(4): 65-69.

MoghassemiS, Hadjizadeh A, Nano-niosomes as nanoscale drug delivery systems: an illustrated review, J. Cont. Rel.2014, 185 (1), 22-36.

Liu T, Guo R, Hua W, Qiu J, Structure behaviors of hemoglobin in PEG 6000/Tween 80/Span 80/H2O niosome system. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2007, 293, 1-3, 255-261.

Bandyopadhyay P, Johnson M. Fatty alcohols or fatty acids as niosomal hybrid carrier: effect on vesicle size, encapsulation efficiency and in vitro dye release. Colloids and Surfaces B: Biointerfaces. 2007, 58, 68-71.

Dingwoke Francis John, Yunus AA, Udokwu Japheth Chigbo, Ugwoke Sunday Paul, Ezeaku Ikenna. Tolnaftate loaded liposomes- design, and in-vitro evaluation. Universal Journal of Pharmaceutical Research. 2016; 1(2): 48-53.

Mehta SK, Jindal N. Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of antitubercular drugs. Colloids and Surfaces B: Biointerfaces. 2013, 101, 434-441.

Waddad AY, Abbad S, Yu F. Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants. Int. J. Pharm. 2013, 456, 2, 446-458.

Balasubramaniam A, Kumar VA, Pillai KS. Formulation and in-vivo evaluation of niosome encapsulated daunorubicin hydrochloride. Drug. Dev. Ind. Pharm. 2002; 28:1181-93.

Yoshioka T, Stermberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triester (Span 85). Int. J. Pharm. 1994; 105:1-6.

Karki R, Mamatha GC, Subramanya G, Udupa N. Preparation, characterization and tissue disposition of niosomes containing isoniazid. Rasayan J Chem. 2008; 1:224-7.

Marianecci C, Rinaldi F, Marzio LD, Ciogli A, Esposito S, Carafa M. Polysorbate 20 vesicles as multi-drug carriers: in vitro preliminary evaluations," Lett. Drug Design and Disc. 2013, 10(3), 212-218.

Begum K, Khan AF, Hana HK, Sheak J, Jalil RU. Rifampicin niosome: preparations, characterizations and antibacterial activity against staphylococcus aureus and staphylococcus epidermidis isolated from acne," Dhaka University J. Pharm. Sci. 2015, 14, 1, 117-123.

Manconi M, Sinico M, Valenti D, Lai F, Fadda AM, Niosomes as carriers for tretinoin: III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin," Int. J. Pharm. 2006, 311, 1-2, 11-19.

Tavano L, Muzzalupo R, Mauro L, Pellegrino M, Andò S, Picci N, Transferrin-conjugated Pluronic niosomes as a new drug delivery system for anticancer therapy, Langmuir. 2013, 29, 41, 12638-12646.

Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery-an overview," Acta PharmaceuticaSinica B. 2011, 1(4), 208-219.

Zhang S, Morris ME. Efflux transporters in drug excretion. In: Wang B, Siahaan T, Soltero R (eds) Drug delivery: principles and applications. Wiley, Hoboken. 2005, 381-398.

Gayatri Devi S, Venkatesh P and Udupa N. Niosomal sumatriptan succinate for nasal administration. Int. J. Pharm. Sci. 2000;62(6):479- 481.

R. Muzzalupo, L. Tavano, R. Cassano, S. Trombino, T. Ferrarelli, and N. Picci. A new approach for the evaluation of niosomes as effective transdermal drug delivery systems. Europ. J. Pharm. Biopharm. 2011, 79(1), 28-35.

Ugochukwu AE, Nnedimkpa OJ, Rita NO. Preparation and characterization of Tolterodine tartrate proniosomes, Universal Journal of Pharmaceutical Research. 2017; 2(2): 22-25.

Manosroi A, Wongtrakul P, Manosroi J. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol," Colloids and Surfaces B: Biointerfaces. 2003, 30, 1-2, 129-138.

Ejiogu Deborah Chioma. Formulation and evaluation of etodolac niosomes by modified ether injection technique. Universal Journal of Pharmaceutical Research. 2016; 1(1): 1-6.

Kapil Kumar, AK Rai. Proniosomes as a drug carrier for transdermal delivery of herbal drug, Journal of Pharmacy Research, 2012; 5(2):887-890.

Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery-an overview. Acta. Pharm. Sin. B. 2011, 1(4):208-219.

Yogesh Sharma, Kapil Kumar*, Sai Krushna Padhy. Formulation and evaluation of Atorvastatin calcium Niosomes, Int. J. Life. Sci. Scienti. Res., 2016, 2 (4), 1-4.

Lawrence J, Chauhan S, Lawrence SM, Barlow D. The formation, characterization and stability of non-ionic surfactant vesicles. STP Pharma Sci. 1996, 6(1):49-60.

Marianecci C, Paolino D, Celia C, Fresta M, Carafa M, Alhaique F. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lungfibro-blasts. J. Control Release, 2010, 147(1):127-135.

Kapil Kumar, AK Rai. Proniosomes as a drug carrier for transdermal delivery of herbal drug, Journal of Pharmacy Research, 2012; 5(2):887-890.

Abdelbary G, El-Gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery," AAPS Pharm. Sci. Tech. 2008, 9(3), 740-747, 2008.

Elsaied Hamada Elsaied, Hamdy Mohamed Dawaba, Elsherbini Ahmed Ibrahim, Mohsen Ibrahim Afouna . Investigation of proniosomes gel as a promising carrier for transdermal delivery of Glimepiride. Universal Journal of Pharmaceutical Research. 2016; 1(2): 1-18.

Reddy BCM, Subbareddy GV. Development, validation and application of UV Spectrophotometric method for the determination of Roxithromycin in bulk and pharmaceutical dosage form. J. Chem. Pharm. Res.2012, 4, 3684-87.

Kazi KM, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M, Kuotsu K. Niosome: a future of targeted drug delivery systems. J. Adv. Pharm. Technol. Res. 2010, 1(4):374-380.

Biju SS, Telegaonar S, Mishra PR, Khar RK. Vesicular system: an overview. Indian J. Pharm. Sci. 2006, 68:141-153.

Biswal S, Murthy PN, Sahu J, Sahoo P, Amir F. Vesicles of non-ionic surfactants (niosomes) and drug delivery potential. Int J Pharm Sci Nanotechnol, 2008, 1(1):1-8.

Kapil Kumar, Rai AK. Development and evaluation of proniosomes as a promising carrier to improve transdermal drug delivery, International research journal of pharmacy, 2011; 2(12):29-31.

Ruckmani K, Sankar V, Sivakumar M. Tissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomes, J. Biomed. Nanotech. 2010, 6(1), 43-51.



How to Cite

Ahmad, S. ., Teotia, D. ., & Kumar, K. . (2018). Niosomes - A PromisingCarrier for Drug Delivery. International Journal of Research and Development in Pharmacy & Life Sciences, 7(4), 3015 - 3021.